ABSTRACT Background: Maternal prenatal folate status has been linked to neurodevelopmental disorders, but the association with child emotional and behavioral problems is unclear. Objectives: We assessed the association of maternal folate status during pregnancy with child emotional and behavioral problems. Also, we examined whether any association between folate status and child problems is a consequence of maternal folic acid supplement use or variation in maternal MTHFR genotype. Design: Within a population-based cohort, we measured maternal plasma folate concentrations in early pregnancy and assessed folic acid supplement use by questionnaire. Mothers of European descent were genotyped for the MTHFR 677 C/T polymorphism. Child emotional and behavioral problems were assessed with the Child Behavior Checklist at 3 y in 3209 children. Results: Children of mothers with prenatal folate deficiency were at higher risk of emotional problems (OR: 1.57; 95% CI: 1.03, 2.38) but not behavioral problems (OR: 1.00; 95% CI: 0.64, 1.56) after adjustment for confounders. A higher risk of emotional problems was also found in children whose mothers started using folic acid supplements late or did not use supplements at all (OR: 1.45; 95% CI: 1.14, 1.84) than in children whose mothers started periconceptionally. However, low plasma folate concentrations only partly explained this association (OR: 1.38; 95% CI: 1.08, 1.78). Although related to plasma folate concentrations, maternal MTHFR genotype did not explain the association of folate status with offspring emotional problems. Conclusion: Low maternal folate status during early pregnancy is associated with a higher risk of emotional problems in the offspring.
INTRODUCTION
Folate, a water-soluble B complex vitamin, is involved in growth and development through 2 distinct metabolic cycles (1, 2) . In one cycle, it is involved in one-carbon transfer reactions for the purpose of DNA synthesis. In the other, folate acts as a methyl donor to the amino acid homocysteine, necessary for methylation of various compounds including DNA, which in turn regulates gene expression. Consequently, homocysteine is inversely related to folate concentration. The enzyme methylenetetrahydrofolate reductase (MTHFR) plays a key role in these cycles: it channels one-carbon units away from DNA synthesis and into the methylation cycle. The activity of the enzyme is influenced by the MTHFR 677 C/T polymorphism. Carriers of the TT variant have a reduced enzymatic activity. At any level of folate or even folic acid supplement intake, these persons have lower folate concentrations than do those carrying the CT or CC variant (3, 4) .
During pregnancy, a time of rapid growth, folate demand increases. Reduced maternal folate status, increased homocysteine status, and MTHFR TT genotype have been associated with an increased risk of neural tube defects in fetuses (5) (6) (7) . Periconceptional supplementation with folic acid, a synthetic form of folate, has been found to reduce this risk (8, 9) .
Prenatal folate status may also affect child behavioral development beyond closure of the neural tube. Few studies have examined the effects of prenatal folic acid supplementation on child behavioral development, and the findings have been inconsistent. Whereas Julvez et al (10) found a positive effect on social competence, Wehby and Murray found supplementation to be unfavorable for the development of the personal-social domain (11) . Previously, we showed in the current cohort that children of mothers who took folic acid supplements during pregnancy were less likely to develop problem behavior at 18 mo (12). Veena et al (13) found that higher folate concentrations during pregnancy predicted better childhood cognitive ability. So far, only Schlotz et al (14) studied the effect of maternal folate concentrations on child problem behavior. They found that lower prenatal folate status increased the risk of hyperactivity and peer problems in childhood.
Recently, associations between maternal MTHFR genotype and prenatal folate and folic acid intake with young children's cognitive (15, 16) and behavioral development have been reported. Schmidt et al (17) found that children of mothers carrying the TT genotype were at higher risk of autism if their mothers did not take vitamins prenatally.
Our objective was to evaluate the effects of maternal plasma folate and homocysteine concentrations in early pregnancy on child emotional and behavioral development. We hypothesized that low maternal folate status in early pregnancy is associated with a higher risk of child emotional and behavioral problems. Also, we examined whether any observed association between folate status and child behavior can be attributed to maternal folic acid supplement use or explained by variation in maternal MTHFR genotype.
SUBJECTS AND METHODS

Study population
The current study was conducted within the Generation R Study -a population-based cohort from early fetal life onward in Rotterdam, Netherlands. The study design was described in detail previously (18, 19) . The study was conducted in accordance with the guidelines proposed in the World Medical Association Declaration of Helsinki and was approved by the Medical Ethics Committee at Erasmus Medical Center, University Medical Center Rotterdam, Netherlands. Written consent was obtained from all participants.
Overall, 6783 mothers were enrolled in the study during early pregnancy (,18 wk gestation). Eligible for the current study were children whose mothers enrolled during early pregnancy, gave birth to a liveborn, and gave consent for postnatal participation (5420 women). We measured plasma folate concentrations in early pregnancy for 4934 of these women. We excluded 34 women because their measure of folate was above the assay range. This resulted in 4900 eligible mothers at baseline.
Mothers' reports on child emotional and behavioral problems at the age of 3 y were available for 3210 children at follow-up. We excluded 1 child with a Child Behavior Checklist (CBCL) score .4 SDs in our analytic sample. In total, data for 3209 children (65%) with maternal folate and behavioral data were included in one or more analyses (Figure 1 ).
Folate and homocysteine concentrations
In early pregnancy (median: 13.1 wk of gestation; 90% range: 10.5-16.9 wk), venous samples were drawn and stored at room temperature before being transported to the regional laboratory for processing and storage for future studies. Processing was aimed to finish within a maximum of 3 h after venipuncture. The samples were centrifuged and thereafter stored at -80°C (20) . To analyze folate and homocysteine concentrations, EDTA plasma samples were picked and transported to the Department of Clinical Chemistry of the Erasmus Medical Center, Rotterdam, in 2008. After being thawed, folate and homocysteine concentrations were analyzed by using an immunoelectrochemiluminesence assay on the Architect System (Abbott Diagnostics BV). The between-run CV depending on folate and homocysteine concentration varied between 1.5-8.9% and 2.1-3.1%, respectively. Analytic ranges for folate and homocysteine concentrations were 1.8-45.3 nmol/L and 1-50 lmol/L, respectively. In the study population of 3209 mothers and children, plasma homocysteine concentrations and information on folic acid supplementation were available in 98.7% and 90.0% of the mothers, respectively.
Maternal folic acid supplement use
Early in pregnancy (gestational age ,18 wk), pregnant women were asked by questionnaire whether they used folic acid supplements or multivitamin preparations and when supplementation was started. In the Netherlands, supplements for pregnant women contain 0.4-0.5 mg folic acid. According to the advice of the Health Council of the Netherlands (21), we categorized folic acid supplement use in the following groups: 1) adequate use (preconceptional start or start within the first 10 wk of pregnancy) and 2) inadequate use (start after the first 10 wk of pregnancy or no use during pregnancy). Also, categorization was in line with 2 previous publications from the Generation R Study, but we retained the group "start after the first 10 wk of pregnancy" in the analyses (12, 22) .
MTHFR genotyping
Maternal DNA was derived from blood samples in early pregnancy. Genotyping of the MTHFR 677 C/T polymorphism (rs1801133) was performed by using TaqMan allelic discrimination assay (Applied Biosystems) and Abgene QPCR ROX mix (Abgene). The genotyping reaction was amplified by using the GeneAmp PCR system 9600 (95°C for 15 min), then 40 cycles of 94°C (15 s) and 60°C (1 min). The fluorescence was detected on the 7900HT Fast Real-Time PCR System (Applied Biosystems), and individual genotypes were determined by using SDS software (version 2.3; Applied Biosystems). Child DNA and MTHFR genotype data were available but not analyzed, because we expected no relation with maternal plasma folate concentrations (23) . Only data from women of European descent (n = 2348) were used in the current study because of the differences in both MTHFR allele frequencies and prevalence of child emotional and behavioral problems among women of various national origins. European descent was based on selfreport and defined as having 2 parents born in a European country (18) . MTHFR genotype was available for 89.6% of women of European descent.
Child emotional and behavioral problems
Mothers were asked to fill out the CBCL for toddlers (CBCL 11/ 2-5) when their child was 3 y of age. The CBCL is a self-administered parents-report questionnaire to measure the degree of emotional and behavioral problems of children. It contains 99 problem items rated on a 3-point scale (0 = not true, 1 = somewhat or sometimes true, and 2 = very true or often true), based on the preceding 2 mo. In the current analyses, we focused on emotional problems and behavioral problems. Emotional problems comprise emotionally reactive and anxious/depressed symptoms and somatic complaints and symptoms of being withdrawn. Behavioral problems comprise attention problems and aggressive behavior. Good reliability and validity have been reported for the CBCL (24) .
Covariates
Several maternal characteristics were considered as possible confounding variables, based on studies of folate concentration, folic acid supplement use, and child behavioral development (25) (26) (27) (28) (29) . Maternal BMI (in kg/m 2 ) in early pregnancy was calculated from length (m) and weight (kg) measured at enrollment. Information on maternal age, national origin, educational level, psychopathology, parity, marital status, pregnancy planning, smoking, and alcohol consumption was obtained by questionnaire. We classified national origin into 5 categories: 1) Dutch, 2) other Western, 3) Turkish or Moroccan, 4) Surinamese or Antillean, or 5) other non-Western. Educational level was assessed by the highest completed education and classified into 3 categories: 1) primary school, 2) secondary school, and 3) higher education. We used the Brief Symptom Inventory to assess maternal psychopathology in midpregnancy (gestational age: 18-25 wk) (30, 31) . The scores on the Global Severity Index (overall psychopathology) and on depressive symptoms were used as continuous variables. Maternal smoking in early pregnancy was categorized as "yes" or "no use." Alcohol consumption in early pregnancy was defined as "one or more glasses per week" compared with "less than one alcoholic beverage per week." The latter group includes both nondrinkers and women who drank alcoholic beverages very occasionally.
Date of birth, birth weight, and sex of the infant were obtained from midwife and hospital registries at birth. Fetal ultrasound examinations were carried out in early pregnancy to establish gestational age at the time the venous samples were drawn and at birth.
Statistical analyses
We used the CBCL emotional and behavioral problem scores as outcome variables. To facilitate a clinical interpretation of problem behavior, and because the CBCL scores were not normally distributed, we analyzed these scores as dichotomous variables. As in previous analyses, we defined a nonoptimal score as the highest 20% of emotional and behavioral item scores (32, 33) .
Multiple logistic regression analyses were used to test for associations between maternal plasma folate concentration and child emotional and behavioral problems. First, we used plasma folate concentration as a continuous variable in the equation (nmol/L per SD). To illustrate a possible dose-response relation for any association with child emotional and behavioral problems, we then divided plasma folate concentrations by quintiles. Next, we tested for a threshold effect of folate deficiency, defined as plasma folate concentrations ,7 nmol/L (n = 131) (34) . Persons with a plasma folate concentration above this cutoff were classified in the reference group, further referred to as "normal folate concentration."
In a similar way, we tested for associations between maternal plasma homocysteine concentration and child emotional and behavioral problems. We tested a threshold effect at a cutoff of 11 lmol/L (2.6% of the study population) (35) and as a lower threshold of 9.1 lmol/L (10% of the study population) using multiple logistic regression analyses.
Logistic regression analysis was also used to test for an association between prenatal folic acid supplement use and child emotional and behavioral problems, with mothers who started folic acid supplementation periconceptionally as the reference category.
Finally, we used a Mendelian randomization approach, that is, we aimed to test whether maternal plasma folate concentration is causally associated to child emotional and behavioral problems, using the maternal MTHFR genotype as a proxy for maternal plasma folate concentration. If a low plasma folate concentration during pregnancy is a cause of emotional and behavioral problems, then children of mothers who have genetic variants associated with lower plasma folate concentrations (T allele) are at higher risk of emotional and behavioral problems. Logistic regression analyses were used to test for a main effect of maternal MTHFR genotype (CC genotype as reference) on child emotional and behavioral problems and for possible mediation of this effect by maternal plasma folate concentration.
Next, we tested an interaction effect and stratified the sample by genotype to test whether any association between maternal plasma folate concentration and child emotional and behavioral problems depended on maternal MTHFR genotype.
All analyses of maternal plasma folate concentration and child emotional and behavioral problems were controlled for gestational age at the time of venipuncture, sex of the child, and age of the child at the time of the measurement (CBCL). Other covariates were selected and included in the models if they changed the effect estimates meaningfully (defined as .5%) (36) . After this changein-estimate criterion, maternal age, national origin, educational level, psychopathology, parity, marital status, and pregnancy planning were included in the current analyses. In contrast, child birth weight and maternal smoking, alcohol consumption, and BMI in early pregnancy were not included in the final models.
Percentages of missing values on covariates ranged from 0.03% to 11.4% (average: 4.4%). Given these low levels of missingness, the mean value was imputed for missing values on continuous variables. For missing values on a categorical variable, a separate "missing" category was included in the regression analyses. Measures of association are presented with 95% CIs. Statistical analyses were carried out by using PASW Statistics, version 17.0 for Windows (SPSS Inc).
Response analyses
Analyses of missing data showed that, compared with children with behavioral data (n = 3209), children without behavioral data (n = 1757) had a shorter gestation [median of 40. 
RESULTS
Descriptive characteristics of the participating mothers and their children are presented by maternal folate deficiency in Table 1 . Children of mothers with folate deficiency in early pregnancy had a lower birth weight than did children of mothers with normal folate status. Folate-deficient mothers were younger, were more often of non-Dutch origin, were less educated, and had higher psychopathology and depression scores than did mothers with a normal plasma folate concentration. They also differed in alcohol use in early pregnancy, pregnancy planning, marital status, and parity. Folate-deficient mothers used folic acid or multivitamin supplements less often. In total, 2485 (78%) of mothers in the study used supplemental folate. Of these, 766 (31%) used folate as a multivitamin supplement.
Maternal plasma folate concentration and child emotional and behavioral problems
The associations between maternal plasma folate concentration and child emotional and behavioral problems are presented in Table 2 . We found no linear association of maternal plasma folate concentration with child emotional (OR: 0.94; 95% CI: 0.85, 1.05) or behavioral (OR: 1.02; 95% CI: 0.92, 1.13) problems after confounders were accounted for. The association is illustrated by dividing plasma folate concentration by quintiles. The odds of developing emotional and behavioral problems is only increased in children of mothers with a plasma folate concentration in the lowest quintile compared with children of mothers with a plasma folate concentration in the highest quintile; however, after adjustment for confounders, the associations were no longer statistically significant. Maternal national origin, educational level, and psychopathology were the most important confounders. Next, we tested the association of maternal folate deficiency (,7 nmol/L; 4% of the study population) during pregnancy with child emotional or behavioral problems. The higher risk of emotional problems in the children of folate-deficient mothers remained significant after adjustment for confounders (OR: 1.57; 95% CI: 1.03, 2.38). In a post hoc analysis, we also defined the lowest 10% plasma folate concentrations (8.5 nmol/L) as the low folate concentration to further test a threshold effect. We found consistent results for the association with child emotional problems in the fully adjusted model (OR: 1.39; 95% CI: 1.04, 1.86), which is in line with a dose-response effect in the lower tail of the folate distribution.
No associations were found between maternal plasma folate concentration and child behavioral problems ( Table 2) . As expected, plasma folate and homocysteine concentrations were negatively correlated (r = 20.21, P , 0.001). However, the plasma homocysteine concentration was, neither as a continuous nor as a dichotomous variable, related to child emotional and behavioral problems (data not shown). We therefore did not further examine any mediating effect of plasma homocysteine concentrations in the association between maternal plasma folate concentrations and child emotional problems.
Maternal folic acid supplementation and child emotional problems
Next, we studied whether maternal plasma folate concentrations mediate the association between folic acid supplementation in pregnancy and child emotional problems. An overview of plasma folate and homocysteine concentrations for each folic acid supplementation category is shown in Table 3 . As expected, the mean plasma folate concentration was lower if folic acid supplementation started later in pregnancy (overall P , 0.001). Plasma folate concentrations were lowest for mothers who did not use folic acid supplements at all. Similarly, but less clear, plasma homocysteine concentrations were higher if supplementation started later in pregnancy.
We found a higher risk of emotional problems at age 3 y in children whose mothers reported any form of inadequate folic acid supplement use (OR: 1.45; 95% CI: 1.14, 1.84) than in children of mothers who reported adequate use. Adjustment for plasma folate concentration attenuated the association, but the results remained significant (OR: 1.38; 95% CI: 1.08, 1.78).
Maternal MTHFR and child emotional and behavioral problems
Furthermore, we examined whether genetic factors are at the root of the association of maternal folate status with child emotional and behavioral development. An overview of mean plasma folate and homocysteine concentrations per MTHFR genotype for women of European descent is shown in Table 4 . MTHFR genotype and allele frequencies were in Hardy Weinberg equilibrium (P = 0.49). Plasma folate concentrations decreased and homocysteine concentrations increased in an allele-dependent dose-response manner (P-trend = 0.001).
The results of a logistic regression analysis of maternal MTHFR genotype on child emotional and behavioral problems, with use of the CC genotype as the reference group, are shown in Table 5 . We found no evidence of an association between maternal MTHFR genotype and the offspring's behavior (P . 0.10 for all comparisons). Similarly, we found no evidence that the effect of plasma folate concentrations on child behavior depended on maternal genotype (P-interaction = 0.14, detailed data not shown). However, the latter analysis was underpowered because only 19 children were exposed to low plasma folate concentrations in the group of mothers carrying the TT variant.
DISCUSSION
This population-based study showed that low maternal folate status in early pregnancy, but not high homocysteine status, is associated with an increased risk of emotional problems in the offspring. Low maternal plasma folate concentrations partly explained the association of folic acid supplementation with child emotional problems. Even though plasma folate concentration was related to MTHFR genotype, we found no association between maternal MTHFR genotype and child emotional and behavioral problems.
Maternal plasma folate concentration and child emotional and behavioral problems
Several potential mechanisms may underlie the effect of low folate status during pregnancy on child emotional problems. First, low maternal plasma folate concentrations directly limit the availability of folate to the fetal cells. This affects de novo DNA synthesis, which results in impairment of cell division (1).
Moreover, neurodevelopment continues after closure of the neural tube. Craciunescu et al (37) reported that folate deficiency in pregnant dams decreased mitosis and increased apoptosis in mouse fetal forebrain during late gestation.
Second, folate is a methyl donor. Low folate availability allows homocysteine status to increase. Possible biological effects of high homocysteine concentration include reduced methylation reactions, such as DNA hypomethylation. Research in epigenetics has shown that DNA methylation is a candidate mechanism by which in utero conditions affect later health (38) , particularly the risk of neural tube defects (39, 40) . We did not find an effect of increased maternal plasma homocysteine concentrations on child behavior. However, usually concentrations .11-15 lmol/L are used to define hyperhomocysteinemia (35) . Plasma concentrations in our study sample were, even among mothers who did not use folic acid supplements, only 7.8 lmol/L on average and thus were probably not high enough to find an effect.
We found an effect of low plasma folate concentrations almost exclusively on emotional problems. If not a chance finding, it may reflect that low socioeconomic status and poverty play a more important role in determining behavioral as compared with emotional problems in children (41) . Alternatively, this reflects the fact that emotional problems are more reliable at young ages. Emotional problems in toddlers have been found to be more stable as compared with behavioral problems (24) .
Maternal folic acid supplementation and child emotional problems
We previously reported a protective effect of folic acid supplementation on child emotional and behavioral problems at 18 mo. Our current findings confirm these results in the same cohort of children for emotional problems at age 3 y. Above all, by including prenatal plasma folate concentrations in our analyses, we were able to investigate to what extent folate status accounts for the effect of folic acid supplementation on child behavior. On the one hand, the results indicate that the use of folic acid supplements helps pregnant women to decrease the risk of emotional problems in the offspring. On the other hand, the effect could certainly not be entirely attributed to maternal folate status. Our assessment of folate status was based on a single measure in early pregnancy in close temporal proximity to the assessment of folic acid supplement use. One measurement, although indicative, is not a reliable reflection of a mother's long-term folate status. Although plasma folate concentrations corresponded to the degree of compliance with supplementation recommendations, fluctuations in concentrations most certainly occurred. Also, ;31% of the women used folic acid as part of a multivitamin supplement. Hence, we cannot rule out that other nutrients contributed to the effect ascribed to folic acid supplements (42) .
Maternal MTHFR and child emotional and behavioral problems
We found no effect of maternal MTHFR genotype on child emotional and behavioral problems, even though MTHFR was related to plasma folate concentration. A first explanation may be that we measured common, nonclinical problems. Previously reported associations for maternal MTHFR genotype concerned disorders such as Down syndrome and schizophrenia (43, 44) , whereas Glaser et al (45) found no association between maternal MTHFR and adolescent's nonclinical psychotic symptoms. Second, the current study can probably not be viewed as a prototypical test of Mendelian randomization. Genetic variants associated with a difference in intermediate phenotypes, such as plasma folate concentrations, typically index lifetime differences in exposure (46) . In the current study, we were interested in the effect of maternal plasma folate concentrations during pregnancy on emotional and behavioral development in preschool children. Possibly, the effect of very low maternal plasma folate concentrations during this crucial period of neurodevelopment cannot be contrasted with the effect of common genetic variations, which typically sort their (small) effect via continuous differences in the intermediate phenotype. Furthermore, the child genotype, which is certainly more relevant than the maternal genotype once the child is born, cannot easily be used to model early intrauterine effects of low plasma folate concentrations.
Possibly, the maternal MTHFR genotype plays a less pronounced role in the DNA synthesis pathway through which low maternal folate concentrations may exert an effect on the development of child emotional problems. In contrast, there may be a more prominent role for the MTHFR genotype in the methylation pathway, in which it-in combination with low folate concentrations-can expose the embryo to higher homocysteine concentrations (2, 47) . Our study, however, was underpowered to detect such an effect because of the small number of TT carriers who were also exposed to low plasma folate concentrations.
Strengths and limitations
The strengths of our study were its large sample size, the combination of data on plasma folate concentration measured early in pregnancy, folic acid supplementation and MTHFR genotype, and the ability to adjust for considerable numbers of covariates. The study also has its limitations. Selective attrition may have influenced our results. Mothers of children not included generally had lower folate concentrations and less favorable socioeconomic circumstances. This selective attrition can only lead to bias if exposed children not included in the study had different levels of behavioral problems. Furthermore, as mentioned earlier, we only had one measure of maternal plasma folate concentration.
Next, in observational studies, residual confounding can never be excluded. A decline in the effect of maternal plasma folate concentration on the offspring's emotional problems was noticeable after adjustment for several maternal characteristics. This indicates that biomarkers themselves can be confounded. It also stresses the substantial role of confounding factors for both maternal folic acid supplement use and plasma folate concentration in their relation to emotional and behavioral problems in the offspring. Further (residual) confounding, for example in terms of behavioral or other lifestyle factors, cannot be excluded. Possibly, not only high socioeconomic status, but also better home environment or other indicators of social status, which are associated with higher plasma folate concentrations, account for the association with child emotional problems.
Relevance
Our large population-based study suggests a role of maternal prenatal folate status in the offspring's behavioral development. In the Netherlands, women of reproductive age are advised to take daily folic acid supplements 4 wk before conception until 8 wk after conception (21) . However, although campaigns to promote folic acid intake in the Netherlands increased supplement use, still about half of the women do not use folic acid supplements in the conceptional period (21, 48, 49) . Folic acid fortification could improve folate status in women of childbearing age. However, fortification alone would not provide the full requirement. It thus remains important to better educate women of childbearing age about folic acid supplement use.
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